Myocardial Extracellular Volume Is not Associated With Malignant Ventricular Arrhythmias in High-risk Hypertrophic Cardiomyopathy
Conclusions Extracellular volume was not increased in implantable cardioverter-defibrillator HCM patients with malignant ventricular arrhythmias vs those without arrhythmias. Our findings do not support the use of ECV (a surrogate of diffuse fibrosis) as a predictor of arrhythmias in high-risk HCM patients.
Source: Revista Espanola de Cardiologia - Category: Cardiology Source Type: research
More News: Arrhythmia | Cancer & Oncology | Cardiology | Cardiomyopathy | CT Scan | Heart | Hypertrophic Cardiomyopathy | PET Scan | Study | Women